27 november 2017 - eapm belfast...

EAPM

2017

B E L F A S T

27 November 2017

European Alliance for Personalised Medicine Congress: Personalising Your Health: A Global Imperative!

10:00 – 10:30 Press Conference

10.30 – 11.15

Opening of EAPM Congress

Co-Chair:Denis HorganExecutive Director, European Alliance for Personalised Medicine (EAPM) Brussels, Belgium

Welcome:David ByrneFormer European Commissioner for Health and Consumer Protection and Co-Chair EAPM, Brussels, Belgium

Mark LawlerChair in Translational Cancer Genomics, Queen's University Belfast, UK

Minister of Health, Northern Ireland (TBC)

Simon HarrisMinister of Health, Republic of Ireland (TBC)

Kersti KaljulaidPresident of Estonia (TBC)

11.15 – 13:00

Opening Plenary Presidential Session: Round Table “Growth in Personalised Healthcare – The promise for future generations”

Co- Chair:Gordon McVieCo-Chair EAPM, Brussels, Belgium

Patrick JohnstonVice Chancellor, Queen’s University Belfast, UK

Mary BakerFormer President European Brain Council, Brussels, Belgium

Mark CaulfieldChief Scientist, Genomics England, Cambridge, UK

Andina – Ioana ValeanENVI Committee Chair, European Parliament, Brussels, Belgium (TBC)

Patrick VallancePresident R&D, GlaxoSmithKline, US (TBC)

13.00 – 13:45 Lunch and Networking

13.45– 15.30 Parallel Sessions

Centre for Cancer Research and Cell Biology 10 Year Anniversary Symposium

The Value of Sustainable Healthcare

European Hematology Association Session – Personalising treatment of blood diseases – Taking advantage of the leukemia/lymphoma genome

Capturing the Global Picture in Precision Medicine

A Tale of Two Cities: a whole system approach to personalised medicine and health

Chair:David WaughDirector, Centre for Cancer Research and Cell Biology, Belfast, UK

Chair:Denis HorganExecutive Director, European Alliance for Personalised Medicine

Chair:Ulrich JägerProfessor of Hematology, Medical University of Vienna, Austria

Chair:Richard BarkerCenter for the Advancement of Sustainable Medical Innovation (CASMI), Oxford/University College London, UK

Chair:Gianni D’ErricoEuropean Funding Officer, Regional Foundation for the Biomedical Research, Lombardy, Milan, Italy

Cancer A paradigm for Personalised Health

Keeping the Person In Personalised Health

Big Data for Better Health

Personalised Health and Human Disease

Personalised Health and Policy Agenda

Driving The Innovation Agenda

EAPM

2017

B E L F A S T

Speakers to be confirmed

Kaisa ImmonenDirector of Policy, European Patient Forum, Brussels, Belgium

"Personalisation in hematology"Ulrich JägerProfessor of Hematology, Medical University of Vienna, Austria


“PPM+The Leeds Care Record: Big Data supporting PM”Dr Geoff HallChief Clinical Information Officer, Leeds Teaching Hospital NHS Trust, Leeds, UK (TBC)

Maarten IJzermanChair Department of Health Technology & Services Research, University of Twente, Netherlands

"The hematology research roadmap"Christine ChomienneInstitut National du Cancer, Paris France

"Early Health Economic Modelling – developing the evidence of value"Dr Bethany ShinkinsTest Evaluation Group Lead, University of Leeds, Leeds, UK (TBC)

The HARMONY project(speaker to be confirmed)

“Overview of the management of people affected by chronic disease”Paolo MocarelliScientific Director of "don Gnocchi Foundation”, Milan, Italy (TBC)

Magda ChlebusDirector Science Policy, EFPIA. Brussels, Belgium (TBC)

“Prevention of Chronic diseases and benefits for the healthcare systems”Prof. Sergio AbrignaniScientific Director Istituto Nazionale di Genetica Molecolare, Milano, Italy (TBC)

"Access to Innovative Medicines"Anton HagenbeekUniversity of Amsterdam - Academic Medical Centre, The Netherlands

“Public Consultation on PM in Lombardy Regions – Overviews and scientific, industrial and policy outcomes”Luca del GobboRegional Ministry University, Research and Open Innovation, Milan, Italy

“Accelerating PM and Health – a whole system approach”Michael Paul MessengerPrincipal Healthcare Scientist, Leeds Institute of Cancer & Pathology, Leeds, UK

15.30 – 17.00

Presidential Session – Shaping Future Healthcare and the One Health Agenda I

Sue Hill OBEChief Scientific Officer, NHS England, UK

Sir John BellRegius Professor of Medicine, Oxford University, and Chairman of the Office for the Strategic Coordination of Health Research, UK (TBC)







EAPM

2017

B E L F A S T

Ian YoungChief Scientific Advisor, Department of Health, Social Services and Public Safety, Belfast, Northern Ireland

Denis LacombeDirector General, European Organisation for Research and Treatment of Cancer, Brussels, Belgium

17.00 – 17:15 Coffee, Posters and Networking

17.15 – 19.00

Presidential Session – Shaping Future Healthcare and the One Health Agenda II

Peter Hongaard AndersonInnovation Fund , Denmark

Atul GawandeProfessor of Health Policy and Management, Harvard T.H. Chan School of Public Health, Boston, USA

Richard BarkerCenter for the Advancement of Sustainable Medical Innovation (CASMI), Oxford/ICL UK

Koen KasProfessor of Biochemistry, University of Gent, Belgium

19.00- 20.00

Special lecture

Alexander EggermontDirector General, Institute Gustave Roussy, Paris, France

20:30 – 22:00

Welcome Reception, Belfast City Hall (hosted by Lord Mayor)

Mike ThompsonChief Executive Officer, Association of British Pharmaceutical Industries, UK

Kersti KaljulaidPresident, Estonia (TBC)

28 November 2017

07:30 – 08:15 Highlights of the Day and Press Briefing

07:30 – 08:30 Meet the Policy Maker Meet the Professor Meet the Professor/Business Leader

Meet the Patent Advocate

Meet the Professor/Business Leader

08:30 – 10:00

Presidential Session: Big Data Saves Lives

Co Chair:Mark LawlerChair in Translational Cancer Genomics, Queen’s University Belfast, UK and Co-Chair Clinical Cancer Genomic Task Team, Global Alliance for Genomics and Health (GA4GH)

Co Chair:Julie WilsonAssociate Director, Welcome Trust Sanger Centre Cambridge UK

Ewan BirneyDirector European Bioinformatics Institute, Cambrdge UK and Chair Global Aliance for Genomics and Health

Andrew MorrisDirector Health Data Research UK

Mene PangalosExecutive Vice President Innovative Medicines and Early Development Biotech Unit, AstraZeneca Cambridge, UK (TBC)

Margaret GraysonChair Northern Ireland Cancer Research Consumer Forum, Belfast, UK







EAPM

2017

B E L F A S T

Ain AaviksooDeputy Secretary General for E-services and Innovation, Ministry of Social Affairs, Estonia

Ernst HafenInstitute of Molecular Systems Biology, ETH Zurich, Switzerland

10:00 – 10:30 Coffee, Posters and Networking

10:00 – 10:30

Speed Networking

Meet the Cancer Patient Meet the Diabetes Patient

Meet the Patient (Brain Diseases)

Meet the Patient with co-morbidities

Meet the Rare Disease Patient

10:30 – 12:15 Parallel Sessions

National Cancer Institute – CCRCB Special Symposium

Precision Medicine in Multi-morbid Inflammatory Disease

Centre for Experimental Medicine (CEM) Special Session: Eyes do not lie – you are what you can see! Options for personalised medicine in eye diseases

European Bioinformatics Institute-Global Alliance for Genomics and Health (GA4GH) Special Session Empowering personalised health through data sharing

Converting Hospitals to a Personalised Health Agenda

Chair:Nick OrrTeam Leader, Institute of Cancer Research, London, UK

Chair:Tunde PetoCentre for Experimental Medicine, Queen’s University Belfast, UK

Chair:Serena ScollenHead of Human Genomics and Translational Data, Elixir, Cambridge, UK

Session Organiser:Pascal GarelChief Executive, Hospital and Healthcare Federation (HOPE), Brussels, Belgium

Marie Therese LandiPrincipal Investigator, Division of Cancer Epidemiology & Genetics, Integrative Tumor Epidemiology , National Cancer Institute Washington, USA (TBC)

"Stratified Medicine in Proinflamatory Disease"Tony BjoursonNorthern Ireland Centre for Stratified Medicine (TBC)

“Pharmacogenetics and the individual patient: the industry perspective”Everson NogocekeBiomarker Experimental Medicine Leader, Roche Pharma Research & Early Development, Roche, Basel, Switzerland

Julie WilsonAssociate Director, Welcome Trust Sanger Centre, Cambridge, UK; Clinical Working Group, Global Alliance for Genomics and Health (GA4GH)

Regional LevelEva Weinreich-JensenVice-President, HOPE & Senior Adviser, Danish Regions, Denmark

Jean Claude ZenklusenDirector, The Cancer Genome Atlas, National Cancer Institute, Washington, USA (TBC)

"Personalised Medicine approaches to immunological mechanism and treatment for major psychiatric disorders"Golam KhandakerUniversity of Cambridge Neuroscience, UK (TBC)

“Precision Ophthalmology: Lessons from age related macular disease”Carel HoyngProfessor of Ophthalmology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands

Serena ScollenHead of Human Genomics and Translational Data, Elixir, Cambridge, UK

“National Level” Michael McBrideChief Medical Officer, Department of Health Northern Ireland, Belfast, UK (TBC)

Aimee KramerDivision of Cancer Epidemiology & Genetics, Infections and Immunoepidemiology Branch, National Cancer Institute, Washington, USA (TBC)

Prof Elisabeth BinderMax Planck Institute of Psychiatry, Heidelberg, Germany

“The myopia epidemic: can we individualise the message?”Caroline KlaverProfessor of Ophthalmology at Erasmus MC & Radboud UMC The Netherlands

Thomas KeaneTeam Leader: EGA, EVA and archive infrastructure EMBL-EBI

Other Speakers to be Confirmed







EAPM

2017

B E L F A S T

“Micronutrients and age related eye disease: from diet through drugs to prevention of blindness”Imre LengyelCentre for Experimental Medicine, Queen’s University Belfast, UK

Torsten SchwedeProfessor of Bioinformatics, Swiss Institute of Bioinformatics, University of Basel, Switzerland

“Curing diabetic eye disease? - from the bench to treating patients as individuals”Alan StittProfessor, Centre for Experimental Medicine, Queen’s University Belfast, UK

Sarion Bowers, Policy Lead Sanger Institute

“How to improve imaging technology to accommodate individual needs?” Anne-Marie Cairns, Global Vice President of Clinical & Medical Affairs, Optos, Halbeath, UK

Jeff Barrett, Director, Centre for Therapeutic Target Validation, Cambridge, UK

12:00 - 12.30Proffered Paper Presentations

Proffered Paper Presentations




12:30 – 13:30 Lunch, Posters and Networking

13:00 – 14:30

Presidential Session: Research Frontiers in Personalised Medicine

Session Chair:Mairead O’DriscollHealth Research Board of Ireland, Dublin,Ireland and IC-Per Med

Holger Hess-StumppDirector, Global External Innovation & Alliance, Oncology, Bayer Healthcare, Leverkusen, Germany (TBC)

13:00 – 14:30

Speaker to be confirmed

William PaoGlobal Head, Oncology Discovery & Translational Area (pRED), Roche, Basel, Switzerland (TBC)

Alberto BardelliPresident, European Association for Cancer Research, Torino, Italy


14:30 – 15:00

Speed Networking

Meet the Cancer PatientMeet the Diabetes

PatientMeet the Patient (Brain

Diseases)Meet the Patient with

co-morbiditiesMeet the Rare Disease

Patient







EAPM

2017

B E L F A S T


Mini Symposium: Breast Cancer: Dealing with Complexity Head on to Better Personalised Treatment

Genomics and Medicine – Crossing the Rubicon

Realising precious therapeutics in neurological disease

CCRCB – ALMAC Session – The Realities of Delivering Personalised Medicine in Clinical Trials

Special Symposium: Implementing existing knowledge and innovation – a European Perspective

Chair:Liam GallagherDirector Conway Institute for Biomolecular Research, University College Dublin, Ireland

Chair:Shane McKeeDirector Northern Ireland Genomics Medicine Centre, Belfast, UK

Chair:Gianpiero CavalleriAssociate Professor in Human Genetics Royal College of Surgeons in Ireland, Dublin, Ireland

Chair:Richard KennedyMcClay Professor in Medical Oncology Queen’s University Belfast, UK

Chair:Peter SelbyPresident, European Cancer Concord (ECC)

Professor Martine PiccartProfessor of Oncology, Université Libre de Bruxelles; Director of Medicine, Jules Bordet Institute, Belgium

Sir John BurnProfessor of Clinical Genetics University of Newcastle, UK

Ken EmancipatorExecutive Medical Director, Merck, New York, USA

Francoise MeunierVice-President, Federation of European Academies of Medicine, Brussels, Belgium

Alric RütherMD, PhD Head, Department of Health Care Quality, International Affairs, Institute for Quality and Efficiency in Health Care (IQWiG), Cologne, Germany (TBC)

Sally JohnVP Genomics and Computational Biology, Biogen, Cambridge, USA (TBC)

Slave PetrovskiNHMRC Fellow, Royal Melbourne Hospital, University of Melbourne, Australia

Darren HodgsonSenior Principal Translational Scientist, AstraZeneca, Stcckport, UK

Arnie PurushothamDirector of King’s Health Partners Cancer Centre (KHPCC), Chair of Breast Cancer at King’s College London (KCL) Trust (TBC)

Professor Fergus CouchProfessor and Chair, Division of Experimental Pathology, Mayo Clinic, USA

Nadeem SarwarPresident, Eisai AiM Institute, Boston USA (TBC)

"eHealth":Mary FitzsimonsMedical Physicist, Beaumont Hospital, Dublin, Ireland

Matt SquiresExecutive Director Oncology Precision Medicine Novartis, Basel,Switzerland

Peter SelbyPresident, European Cancer Concord (ECC)


“Clinical integration”Norman DelantyProfessor of Clinical Neurological Sciences, Beaumont Hospital, Dublin, Ireland


16:30 – 17:30 Proffered Paper Presentations






17:30 – 19:00

Imaging and Personalised Medicine

Chair:Bernd HammPresident, European Society of Radiology

Harmony Session

Chair:Carin SmandManaging Director, EHA (TBC)

Clinical Innovation Showcase: ‘Northern Ireland Clinical Research Network(NICRN) : supporting clinical research in personalised medicine’

Co-Chairs:Paul Biagioni, Maurice O’KaneNICRN

19:00 – 20:00 CCRCB Lecture

19:00 – 20:00 Poster Session







EAPM

2017

B E L F A S T

20:30 – 22:30

Gala Dinner Titanic Belfast

Taavi Rõivasformer leader of the Reform Party and former Prime Minister of Estonia (TBC)

29 November 2017


07:30 – 08:30 Meet the Policy MakersMeet the Professor/

Business LeaderMeet the Professor/

Business LeaderMeet the Policy Makers


08:00 – 09:30

Presidential Session: Is precision medicine the route to a healthy world?

Session Chair: John BowisFormer Minister for Health UK and Former MEP

Taavi Rõivasformer leader of the Reform Party and former Prime Minister of Estonia (TBC)

Harold VarmusNew York Genome Centre, USA (TBC)

Carlos MoedasCommissioner, DG Research, Science and Innovation, Brussels, Belgium (TBC)

Ruth McKernan CBEChief Executive, Innovate UK (TBC)

Ian BanksPresident, European Men's Health Forum

Roger PerlmutterExecutive Vice President Merck & Co and President Merck Research Laboratories MSD, New Jersey, USA (TBC)



Personal Oncology Approaches - reflections from both sides of the pond

The ‘molecularly unstratified’ patient: a focus for moral, psycho-social and societal research

Genomics and Reimbursement

Immunotherapy: The next Big Thing?

Preserving Health – what can we do at European Level?

Chair:Etienne RichterAssociate Director, CIHR Institute of Genetics, Montreal, Canada

Chair:Deborah AlsinaChief Executive MBE, Bowel Cancer UK

Chair:Jonathan TrueloveVice President, General Counsel – International, Genomic Health, Geneva, Switzerland

Chair:Gennaro CilibertoScientific Director, IRCCS, Instituto Nazionale Tumori “Regina Elena, Rome, Italy

Chair:Tit AlbrehtInstitute of Public Health, Slovenia







EAPM

2017

B E L F A S T

Fabien CalvoScientific Director, Cancer Core Europe, Paris, France

Tim MaughanProfessor of Clinical Oncology, University of Oxford; MRC/CRUK Stratification in Colorectal Cancer Consortium

Sheila WalcoffFounder and CEO, Goldbug Strategies, Washington, USA

“Immunophenotypes and antigenomes of solid cancers”Zlatko TrajanoskiDirector, Division for Bioinformatics, Biocenter, Innsbruck Medical University (TBC)

Sebastian SchmidtHead of Strategy and Medical Affairs Computed Tomography at Siemens Healthineers

“Biomarkers for Pediatric Glioblastoma through Genomics and Epigenomics”Nada JabadoAssociate Professor of Pediatrics, McGill University Health Centre, Montreal, Canada

Joshua HordernAssociate Professor of Christian Ethics, University of Oxford; Oxford Healthcare Values Partnership, University of Oxford

Stephen LeeBiosciences Team Manager, Medicines and Healthcare products Regulatory Agency, London, UK (TBC)

“Clonal neoantigens and sensitivity to immune checkpoint blockade”Sergio QuezadaProfessional Research Fellow, Research Department of Hematology, UCL Cancer Institute (TBC)

“Public health genomics”Dr Marc Van den BulckeHead Cancer Centre, OD Public Health and Surveillance Scientific Institute of Public Health, Belgium

“Personalized Cancer Immunotherapy”Denis Claude RoyDirector Cellular Therap Laboratory, Scientific Director, Centre de recherche, Hospital Maisonneuve-Rosemont, Montreal, Canada

Richard SullivanChair in Cancer Policy and Global Health, Kings College London

Sue SpencerHead of Global Medical Device Services, UL, UK (TBC)

“Development of neoantigen-based cancer”Ugur Sahinco-founder and CEO of BioNTech AG, Mainz, Germany (TBC)

“Cancer screening”Dr Ahti AnttilaResearch Director of the Mass Screening Registry of the Finnish Cancer Registry (TBC)

“Personalized Oncogenomics (POG), The BC Cancer Agency’s Personalized Oncogenomics Program”Marco MarraDirector and Distinguished Scientist, Canada’s Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, Canada

Alison HallHead of Humanities, PHG Foundation, Cambridge, UK

Dr Panos KanavosReader in International Health Policy Department of Social Policy, London School of Economics, London, UK

“Design and testing of novel concepts for adoptive immunotherapy of cancer”Ton SchumacherGroup Leader, Immunology, Netherlands Cancer Institute (TBC)

Michel ColemanProfessor of Epidemiology and Vital Statistics, Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (TBC)

Liz MorrellPostdoctoral researcher, Centre for the Advancement of Sustainable Medical Innovation (CASMI), Radcliffe Department of Medicine, University of Oxford, UK

British Standards Institution representative(speaker to be confirmed)

Jim CassidyTranslational Medicine Oncology, Roche (TBC)

“Survivorship issues”Dr Claudia FerrariDepartment of Training and Demography for Health Professionals, The French National Cancer Institute (TBC)

Rob HorneProfessor of Behavioural Medicine, UCL School of Pharmacy; Centre for the Advancement of Sustainable Medical Innovation, London, UK

Stephan SchererVP Global Head Correlative Science, Novartis (TBC)







EAPM

2017

B E L F A S T

Alastair KentChair Rare Disease UK; Director, Genetic Alliance UK

11:30 – 12:00Proffered Paper Presentations






13:30 – 15.00

Presidential Session: Female Leaders and Innovators Forum

Session Chair:Mary HarneyFormer Minister for Health and Deputy Prime Minister, Ireland

Francoise MeunierDirector of Special Projects, European Association for the Research and Treatment of Cancer, Brussels, Belgium, Vice-President, Federation of European Academies of Medicine, Brussels, Belgium

Sabine TejparHead of Molecular Digestive Oncology, KU Leuven (TBC)

Speaker to be Confirmed


Patient Advocacy Award


Princess Margaret Cancer Centre – CCRCB Special Symposium

Personalised Medicine and Public Health: Two Sides of the Same Coin?

Fixing Cystic Fibrosis Transmembrane Conductance Regulator (CFTR): Targeting therapies which make a difference

Genomics, DNA and Diaspora

Chair: Lillian SiuProfessor of Medicine, Princess margaret Cancer Centre, University of Toronto, Canada

Chair: Walter RicciardiInstituto Superiore di Sanità Italy

Chair:Stuart ElbornImperial College and Royal Brompton Hospital, London and Queens University Belfast, UK

Co-Chair:Eimear KennyAssistant Professor, Icahn School of Medicine at Mount Sinai, NY, USA

Co-Chair:Joe McHugh T.D.Minister of State for the Diaspora and International Development (TBC)

“Risk Stratification Approaches in the Management of Locoregionally Advanced Head and Neck Squamous Cell Cancer"Jean Pascal MachielsMD, PhD, Université catholique de Louvain, Brussels, Belgium


Fred van GoorResearch Fellow, Vertex, San Diego, US

John GreallyProfessor, Faculty Scholar for Epigenetics, Albert Einstein College of Medicine, New York, USA







EAPM

2017

B E L F A S T

“The Changing Epidemiological and Molecular Landscape of Head and Neck Squamous Cell Cancer: A Global Perspective”Hisham MehannaMBChB, PhD, University of Birmingham, Birmingham, UK

Frank KeeDirector, UKCRC Centre for Excellence for Public Health Research (NI), Queen’s University Belfast, UK

Janet AllenDirector of Strategic Innovation, Cystic Fibrosis Trust, Southampton, UK (TBC)

Dan BradleyPrincipal Investigator, molecular Population Genetics, Smurfit Institute of Genetics, Trinity College Dublin

“Oncolytic Viruses and Immune Checkpoint Inhibitors in the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Cancer”Kevin HarringtonMBBS, PhD, The Institute of Cancer Research, London, UK

Kaisa ImmonenDirector of Policy, European Patient Forum

Michelle Francis NaylorConsultant Psychiatrist, Northern Health and Societal Care Trust, Galgorm Private Clinic, Belfast, UK (TBC)

Eimear KennyAssistant Professor, Icahn School of Medicine at Mount Sinai, NY. USA

Xavier Prats MonneDirector-General for Health and Food Security – DG SANTE, European Commission, Brussels, Belgium (TBC)

Lorraine MartinProfessor of Molecular Pharmaceutics, School of Pharmacy, Queen’s University Belfast, UK (TBC)

Tõnu EskoDeputy Director of Research, Estonian Biobank, Estonian Genome Center, University of Tartu, Estonia (TBC)

16:30 – 17:00 Proffered Paper Presentations






Speed Networking

Meet the Cancer Patient Meet the Diabetes Patient




17:30 – 19:00

Shooting for the Moon or Flying too near the Sun: Crossing the Value Rubicon in Precision Care

Co-Chair:Mark LawlerChair in Translational Cancer Genomics, Queen’s University Belfast, UK

Co-Chair:Richard SullivanDirector, Institute of Cancer Policy, King’s College London UK

Tito FojoProfessor of Medicine, Columbia University, New York, USA (TBC)

Mark LawlerChair in Translational Cancer Genomics, Queen’s University Belfast, UK

Chris BoothAssociate Professor of Oncology and Chair in Population Cancer Care, Princess Margaret Cancer Centre, University of Toronto, Canada (TBC)

Virginia AchaExecutive Director, Research, Medical and Innovation, Association of the British Pharmaceutical Industry (ABPI), UK







EAPM

2017

B E L F A S T

19:00 – 20:00 Poster Session

20.00 - late Whiskey tasting and Special Performance

30 November 2017


07:00 - 08:00 Meet the Professor Meet the Professor/

Business LeaderMeet the Policy Maker

Meet the Patient Advocate


08:00 – 09:30

Presidential Session: Public-private partnership and personalised medicine

Chair:Pierre MeulienInnovation Medicines Initiative (IMI)

Kaja KallasMember of the European Parliament (TBC)

Francesco De LorenzoPresident, European Cancer Patient Coalition, Brussels, Belgium




The Challenges of Precision Oncology Drug Development and Implementation

Personalised Health and neglected disease

We are what we eat – preserving health through enhanced nutrition

The Global Challenge: Make Pathology great again (TBC)

Co Chair:Andrew BiankinRegius Chair of Surgery/Director of Translational Research Centre, University of Glasgow

Co Chair:Simon HollingsworthExecutive Director Oncology; Global Project Director, AstraZeneca, Cambridge, UK

Chair:Alastair KentChair Rare Disease UK; Director, Genetic Alliance UK

Chair:Christopher Elliott, Chair of Food Safety & Microbiology, Pro Vice Chancellor Faculty of Medicine, Health and Life Sciences, Queen’s University Belfast, UK

Chair:Kathy OliverFounding Co-Director, International Brain Tumour Alliance (IBTA) (TBC)

“Challenges of Contemporary Therapeutic Development”Simon HollingsworthExecutive Director Oncology; Global Project Director, AstraZeneca, Cambridge, UK

Yann Le CamChief Executive Officer of EURORDIS-Rare Diseases Europe (TBC)

Precision Nutritional Catering for the Vulnerable: Can this be achieved?”Professor Moira DeanInstitute for Global Food Security, Queen’s University, Belfast

Kenneth FlemingSenior Adviser for pathology, Centre for Global Health NCI, Washington (TBC)







EAPM

2017

B E L F A S T

“Diversity and Defining Actionability of Molecular Events”Philip BeerPrecision oncology, cancer genomics and next-generation therapeutics - ‎Cure Forward Corp., Cambridge, UK

Anders OlausonChair, NGO Committee for Rare Diseases, United Nations, New York

“Delivering a breakthrough in human nutrition and health through delivery of omega oils in chicken meat”Professor Alice StantonRoyal College of Surgeons in Ireland

John FlaniganSenior Advisor for Non Communicable Diseases, Center for Global Health, National Cancer Institute, USA (TBC)

“Finding patient for trials/Finding Trials for Patients”IBM Watson Speaker(TBC)

Maria Luisa SilvaDirector of United Nations Development Program (UNDP) Office in Geneva (TBC)

Manuel Salto TellezChair of Molecular Pathology, Queen’s University Belfast, UK (TBC)

“Effective Strategies for approval and adoption” Robert HemmingsKrishna PrasadMHRA (TBC)

Ana RathDirector, Orphanet, Paris, France

Sue HortonProfessor and GICI Chair in Global Health Economics, University of Waterloo, Canada (TBC)

“Composite Datasets and Knowledge Banks”Andrew BiankinRegius Chair of Surgery/Director of Translational Research Centre, University of Glasgow, UK

Lai Meng LooiSenior Professor of Pathology, University of Malaya, Malaysia (TBC)

11:30 – 12:00 Proffered Paper Presentations?

Proffered Paper Presentations?





13:00 – 14:30

Presidential Session: Regulating the future – Balance of patient safety and facilitating Innovation (EMA – FDA)

Session Chair:Denis HorganExecutive Director, European Alliance for Personalised Medicine

Robert NussbaumChief Medical Officer Invitae (TBC)

Emily O’ReillyEuropean Ombudsman (TBC)

Urve PaloMinister of Entrepreneurship and Information Technology, Estonia (TBC)

Kathy OliverInternational Brain Tumor Alliance IBTA

Michael ZaiacVice President , Medical Affairs , Haem/Onc, Celgene, Basel, Switzerland (TBC)

Guido RasiExecutive Director, EMA, London, UK (TBC)








EAPM

2017

B E L F A S T

Speed Networking

Meet the Cancer Patient Meet the Diabetes Patients





EAU Special Session Every Prostate cancer is unique: Personalised prostate cancer diagnosis and management

Discovery Network: a new approach to driving research

Diabetes: A Personalised Health Epidemic

Molecular Diagnostics – Enabling the Personalised Medicine Revolution

HTA, Payers & the European Medicines Agency – Crossing the Rubicon

Chair:Hain Van PoppelEuropean Association of Urology

Chair:Peter KapteinInspire2Live, The Netherlands

Chair:Olivier ArnaudSenior Director, Juvenile Diabetes Research Foundation

Co-Chair:David BartonNational Centre for Medicial Genetics Crumlin

Co-Chair:Mario PazzagliUniversity of Florence, Italy

Chair:Lou GarrisonUniversity of Washington, USA

Nicolas MottetUrology Department Head at CHU St Etienne - Université Jean Monnet, St Etienne

Stephen FriendChariman, Co-Founder and Past President Sage Bionetworks; Leader Health Team, Apple Inc.


“The new IVD regulation”David BartonChief Scientist, National Centre for Medical Genetics Crumlin; (TBC)

Clare HagueDirector of Health Economics & Outcomes research Medical Affairs, Celgene

Rodolfo MontironiPresident, International Society of Urological Pathology

Mark LawlerChair in Translational Cancer Genomics, Queen’s University Belfast

“A Workflow for molecular diagnostics in clinical oncology”Mario PazzagliProfessor of Clinical Biochemistry, Department of Clinical and Experimental Biochemical Science University of Florence, Italy (TBC)

Carole LongsonDirector, Centre for Health Technology Evaluation and Executive Director, National Institute for Health Care & Excellence (NICE), London, UK


Charles SawyersChair, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Centre, New York, USA (TBC)

“Quality Assessment of Molecular Diagnostics in Oncology”Victoria WurcelManager HTA and Economic Policies, MedTech Europe, Brussels, Belgium

Hans-Georg EichlerMD, MSc, Senior Medical Officer, European Medicines Agency (EMA), London, UK

Ian BanksPresident, European Men's Health Forum

Robert Jan SmitsDirector-General of DG Research and Innovation – European Commission (TBC)

“Benchmarking the quality of next generation sequencing in Clinical Oncology”Simon PattonDirector at European Molecular Genetics Quality Network (EMQN) - European Molecular Genetics Quality Network (EMQN) (TBC)

Lars PedersenMSc, PhD, Professor, Department of Clinical Epidemiology, Aarhus University, Aarhus, Denmark (TBC)







EAPM

2017

B E L F A S T







Rob VriesHubrecht institute / The HUB foundation for Organoid technology, Hubrecht, The Netherlands

Casper Van EijckSurgeon at Erasmus MC – Rotterdam, The Netherlands

16:30 – 17:30

Closing of conference: Keeping the promise and preparing for the future

Jevgeni OssinovskiMinister of Health, Estonia (TBC)

Vytenis AndriukaitisEuropean Commissioner for Health and Food Safety, Brussels, Belgium (TBC)

David ByrneChair European Alliance for Personalised Medicine, Brussels, Belgium

Charles SawyersChair, Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Centre, New York, USA (TBC)

Stephen FriendChariman, Co-Founder and Past President Sage Bionetworks; Leader Health Team, Apple Inc.

27 november 2017 - eapm belfast...

Documents